SCHEMBL7347301

SCHEMBL7347301

CCCCCCC(CC)NN

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.42
SPHK1 Q9NYA1 2/20 0.40
LMNA P02545 2/20 0.39
DNM1 Q05193 4/20 0.39
EPHX1 P07099 1/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
CYP2D6 P10635 2/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
PLA2G1B P04054 1/20 0.38
PLA2G2A P14555 1/20 0.38
GMNN O75496 1/20 0.38
POLB P06746 1/20 0.38
THPO P40225 1/20 0.38
MTOR P42345 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12650308 1.00 OPRM1 (0.42) OPRM1SPHK1LMNADNM1EPHX1
SCHEMBL10993235 1.00 OPRM1 (0.42) OPRM1SPHK1LMNADNM1EPHX1
Hydrochloric Acid SCHEMBL28958538 0.98 OPRM1 (0.41) OPRM1SPHK1LMNADNM1EPHX1
SCHEMBL18733079 0.98 OPRM1 (0.44) OPRM1SPHK1LMNADNM1EPHX1
SCHEMBL25338916 0.90 OPRM1 (0.46) OPRM1SPHK1LMNADNM1EPHX1
SCHEMBL22930967 0.90
SCHEMBL27331212 0.90
SCHEMBL25979188 0.90 OPRM1 (0.46) OPRM1SPHK1LMNADNM1EPHX1
SCHEMBL7344683 0.86 OPRM1 (0.42) OPRM1SPHK1LMNADNM1EPHX1
SCHEMBL12124043 0.86 OPRM1 (0.42) OPRM1SPHK1LMNADNM1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1151155-C 1, 5-dihydro-pyrazolo [3, 4-D ] -pyrimidone derivatives 2004-05-26 CN disclosed
US-6174884-B1 CARDIOVASCULAR DISORDERS; CEREBROVASCULAR DISEASES; VASCULAR SYSTEM DISORDERS, ESPECIALLY THE PERIPHERAL BLOOD VESSELS; UROGENITAL DISORDERS; HYPOTENSIVE AGENTS; ANTIARRYTHMIA AND -ISCHEMIC AGENTS; PHOSPHODIESTERASE ACTIVITY BAYER AKTIENGESELLSCHAFT (DE) 2001-01-16 US disclosed
CN-1255133-A 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives BAYER AG (DE) 2000-05-31 CN disclosed
EP-0973774-A1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2000-01-26 EP disclosed
WO-1998040384-A1 1,5-DIHYDRO-PYRAZOLO[3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1998-09-17 WO disclosed
US-4268486-A REACTING WITH A HYDRAZINE COMPOUND AND SEPARATING TRIVALENT CHROMIUM COMPOUNDS OLIN CORPORATION (US) 1981-05-19 US disclosed
US-3962113-A METHOD FOR ACCELERATING OXYGEN REMOVAL EMPLOYING AN AQUEOUS SOLUTION OF AN ALKYL HYDRAZINE OLIN CORPORATION (US) 1976-06-08 US disclosed